TransMedics Group, Inc.
TransMedics Group, Inc.
TMDX
Valuace
30
Růst
100
Zdraví
69
Cena
$ 122.30
Dnes
--0.32 (-0.22%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
4.2B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
26%
ROA
10%
PE
24
PS
8
Cena 1R
55-156
⌀ Cena
118.81
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

TransMedics Group, Inc., společnost zabývající se lékařskou technikou v komerčním měřítku, se zabývá transformací transplantační terapie pro pacienty s selháním orgánů v konečném stadiu ve Spojených státech a mezinárodně. Společnost nabízí Organ Care System (OCS), přenosný perfuzní, optimalizační a monitorovací systém, který využívá vlastní a přizpůsobenou technologii k replikaci téměř fyziologických stavů dárcovských orgánů mimo lidské tělo. Jeho systém péče o orgány zahrnuje OCS LUNG pro zachování standardních kritérií dárcovské plíce pro transplantaci dvojité plíce; OCS Heart, technologii pro mimotělní perfuzi a uchování dárcovských srdcí; a OCS Játra pro uchování dárcovských jater. Společnost byla založena v roce 1998 a sídlí v Andoveru ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
728
Založení
2019-05-02
Adresa
200 Minuteman Road
CEO
Waleed H. Hassanein

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016
Total Revenues605.5605.5441.5241.693.530.325.623.613.07.76.2
Cost of Revenues242.7242.7179.587.528.29.19.09.77.35.55.4
Gross Profit362.8362.8262.1154.165.321.216.613.95.72.10.8
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues160.8143.8157.4143.5121.6108.8114.396.981.266.4
Cost of Revenues67.459.260.855.349.647.945.137.033.325.8
Gross Profit93.484.696.688.272.060.869.259.947.940.7
Operating Income TTM 2025202420232022202120202019201820172016
R&D Expenses0.00.00.036.126.822.318.819.913.715.015.6
Selling General & Admin Expenses0.00.00.0119.669.938.324.223.612.37.68.1
Depreciation & Amortization27.227.219.88.2-1.0-0.91.70.80.80.60.4
Total Operating Expenses254.2254.2224.6182.896.760.643.043.526.022.623.8
Operating Income108.6108.637.5-28.7-31.4-39.4-26.4-29.6-20.2-20.4-23.0
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.010.838.3
Selling General & Admin Expenses0.00.00.00.00.00.00.00.034.630.7
Depreciation & Amortization7.56.86.76.15.75.24.64.43.71.9
Total Operating Expenses72.161.360.060.863.456.956.747.445.369.0
Operating Income21.323.336.627.48.63.912.512.42.6-28.3
Net Income TTM 2025202420232022202120202019201820172016
Interest Income2.50.00.012.50.00.00.00.00.00.00.0
Interest Expense13.813.814.410.83.73.94.04.42.71.11.0
Other Expense-1.1-1.1-1.72.1-4.7-4.8-2.3-3.9-0.80.7-0.1
IBT107.5107.535.8-26.7-36.2-44.2-28.7-33.5-23.7-20.8-24.1
Income Tax Expense-82.8-82.80.3-1.60.10.00.00.00.00.01.0
Net Income190.3190.335.5-25.0-36.2-44.2-28.7-33.5-23.8-20.8-24.1
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.00.02.50.02.93.33.43.64.85.2
Interest Expense3.43.53.53.53.63.63.63.63.63.6
Other Expense0.4-0.3-0.4-0.8-1.70.3-0.40.01.31.4
IBT21.623.036.226.77.04.212.212.43.9-26.9
Income Tax Expense-83.8-1.31.31.00.10.00.00.2-0.2-1.5
Net Income105.424.334.925.76.94.212.212.24.0-25.4
Per Share Data TTM 2025202420232022202120202019201820172016
EPS$0.00$0.00$0.00$-0.77$-1.23$-1.60$-1.16$-2.36$-1.23$-1.44$-1.66
EPS Diluted$0.00$0.00$0.00$-0.77$-1.23$-1.60$-1.16$-2.36$-1.23$-1.44$-1.66
Shares Outstanding34.234.033.232.529.627.624.714.219.214.514.5
Diluted Shares Outstanding40.940.535.232.529.627.624.714.219.214.514.5
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.12$-0.78
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.12$-0.78
Shares Outstanding34.234.133.933.733.633.433.132.832.632.6
Diluted Shares Outstanding40.940.740.639.935.235.735.334.734.232.6
Current Assets TTM 20242023202220212020201920182017
Cash And Equivalents362.8336.7394.8201.225.624.620.120.211.9
Short Term Investments0.00.00.00.066.9101.160.60.012.7
Total Cash & ST Investments362.8336.7394.8201.292.5125.680.720.224.7
Accounts Receivable81.297.763.627.65.96.96.63.40.9
Inventory48.746.644.220.614.911.911.29.38.0
Other Current Assets16.716.38.02.95.52.31.51.80.5
Total Current Assets509.3497.2510.7252.3118.7146.8100.034.834.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents466.2400.6310.1336.7330.1362.8350.2394.8427.1582.2
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments466.2400.6310.1336.7330.1362.8350.2394.8427.1582.2
Accounts Receivable80.7104.9142.097.790.181.281.963.660.747.5
Inventory44.538.943.446.652.248.748.544.239.430.5
Other Current Assets21.613.810.416.320.116.77.68.09.62.4
Total Current Assets613.0558.1505.9497.2492.5509.3488.3510.7536.7662.7
Long-Term Assets TTM 20242023202220212020201920182017
Net Property, Plant & Equipment234.9292.5180.524.415.74.84.83.52.5
Goodwill11.511.512.00.00.00.00.00.00.0
Intangible Assets2.32.22.40.00.00.00.00.00.0
Long-Term Investments0.50.00.00.00.00.00.00.00.0
Other Long-Term Assets0.10.70.60.50.50.50.53.90.5
Total Long-Term Assets249.3306.9195.424.916.25.35.37.43.0
Total Assets758.6804.1706.0277.1134.9152.0105.342.237.0
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment318.8318.1317.3292.5278.7234.9220.6180.5137.926.9
Goodwill11.511.511.511.511.511.512.012.011.70.0
Intangible Assets2.02.02.12.22.22.32.32.42.40.0
Long-Term Investments0.00.50.00.00.00.50.50.50.50.8
Other Long-Term Assets0.70.20.70.70.70.10.10.10.60.1
Total Long-Term Assets333.0332.4331.6306.9293.1249.3235.5195.4152.527.7
Total Assets946.0890.5837.5804.1785.6758.6723.8706.0689.2690.4
Current Liabilities TTM 20242023202220212020201920182017
Accounts Payable13.010.312.73.36.71.27.24.73.5
Short-Term Debt2.12.74.11.40.00.00.00.01.8
Other Current Liabilities37.745.236.218.616.310.48.77.55.3
Current Liabilities54.359.954.923.723.211.916.112.610.9
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable12.29.510.610.313.113.09.212.712.87.0
Short-Term Debt8.23.02.82.75.14.32.14.14.03.8
Other Current Liabilities56.042.540.145.239.635.636.936.229.721.0
Current Liabilities79.756.655.659.960.054.350.254.949.132.0
Long-Term Liabilities TTM 20242023202220212020201920182017
Long-Term Debt507.8515.6513.966.18.634.734.133.76.8
Capital Leases6.69.09.78.98.60.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.0
Total Liabilities568.7575.5568.889.867.048.150.747.0205.7
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt456.5515.8515.6515.6515.6514.4514.1513.9513.7513.1
Capital Leases7.70.08.39.09.66.67.27.710.210.3
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities590.8572.4571.2575.5575.7568.7564.4568.8562.8545.1
Total Common Equity TTM 20242023202220212020201920182017
Common Stock669.4697.2641.1666.3510.5502.2424.1331.20.0
Retained Earnings-479.3-468.2-503.7-478.7-442.4-398.2-369.5-335.9-312.2
Comprehensive Income-0.2-0.4-0.2-0.2-0.2-0.10.0-0.1-0.1
Total Common Equity189.9228.6137.2187.467.9103.954.6-4.8-168.7
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock738.4725.7709.2697.2685.3669.4651.2641.1634.5627.7
Retained Earnings-383.3-407.7-442.6-468.2-475.1-479.3-491.5-503.7-507.7-482.3
Comprehensive Income0.10.1-0.3-0.4-0.2-0.2-0.2-0.2-0.3-0.2
Total Common Equity355.2318.1266.3228.6209.9189.9159.5137.2126.5145.2
Other TTM 20242023202220212020201920182017
Total Debt516.5518.3515.967.68.634.734.133.78.7
Book Value189.9228.6137.2187.467.9103.954.6-4.8-168.7
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value355.2318.1266.3228.6209.9189.9159.5137.2126.5145.2
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016
Net Income3.0190.335.5-25.0-36.2-44.2-28.7-33.5-23.8-20.8-24.1
Depreciation & Amortization14.627.219.88.23.51.81.61.20.80.60.4
Stock-Based Compensation25.436.933.219.810.36.92.40.90.10.10.0
Change Working Capital-49.017.3-45.0-44.3-26.83.0-5.6-1.6-4.3-2.8-0.9
Change In Accounts Receivable-31.614.0-34.3-33.8-21.70.8-0.2-3.2-2.50.5-0.8
Change In Accounts Payable5.10.0-1.47.0-3.35.1-5.83.40.2-0.71.1
Change In Inventories-25.0-7.7-8.4-28.1-8.0-4.9-1.7-4.1-2.7-2.5-1.6
Other Non-cash Items87.44.85.430.03.41.40.50.50.20.10.1
Cash from Operations23.70.00.0-13.0-45.8-28.9-30.3-32.3-26.0-23.1-24.1
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income105.424.334.925.76.94.212.212.24.0-25.4
Depreciation & Amortization7.56.86.76.15.75.24.64.43.71.9
Stock-Based Compensation9.49.19.49.010.80.00.00.05.75.2
Change Working Capital-4.927.940.2-44.4-5.8-11.20.2-28.1-5.6-15.5
Change In Accounts Receivable-3.624.137.5-44.1-7.8-8.80.8-18.4-2.8-11.1
Change In Accounts Payable-2.12.5-1.20.8-3.10.03.8-2.00.42.9
Change In Inventories-6.5-6.93.72.04.1-4.6-2.3-5.6-7.1-10.1
Other Non-cash Items0.81.30.40.82.28.78.78.10.528.3
Cash from Operations0.00.00.00.00.00.00.00.08.3-6.9
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016
Capital Expenditure-244.7-59.30.0-151.8-11.9-3.5-0.5-0.2-0.4-0.3-1.5
Acquisitions0.00.00.4-14.90.10.00.00.00.00.00.0
Investments0.00.00.00.0-10.5-72.0-121.8-82.40.0-19.2-46.5
Sales of Investment0.00.00.00.076.9104.880.722.012.744.38.3
Other Investing Activities-69.30.00.0-27.2-0.10.00.00.00.00.00.0
Cash from Investing-259.60.00.0-194.054.529.3-41.6-60.512.324.9-39.7
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-15.5-7.6-9.1-27.0-13.6-48.2-23.8-44.2-41.8-134.9
Acquisitions0.00.00.00.00.00.40.00.014.9-14.9
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.0-42.1-27.2
Cash from Investing0.00.00.00.00.00.00.00.0-41.8-149.8
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016
Debt Repaid-407.90.00.0445.4-36.10.0-2.20.0-9.10.00.0
Debt Issued409.4518.32.3893.895.0-26.12.80.534.18.70.0
Issuance of Common Stock16.30.00.00.0139.90.075.797.40.00.00.0
Repurchase of Common Stock1.2-0.10.01.00.50.40.40.00.00.00.0
Dividends Paid0.00.00.00.00.00.0-0.40.00.00.00.0
Other Financing Activities1.70.00.0-52.163.61.02.1-4.631.10.063.5
Cash from Financing16.30.00.0400.4167.91.475.592.722.10.063.5
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued464.7-54.10.40.10.11.70.30.30.30.6
Issuance of Common Stock0.00.00.00.00.00.00.00.00.91.5
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.60.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.91.5
Cash from Financing0.00.00.00.00.00.00.00.00.91.5
Cash position TTM 2025202420232022202120202019201820172016
Net Change in Cash-219.7151.7-58.2193.6175.61.04.5-0.18.32.1-0.2
Closing Cash Balance362.8488.9337.2395.3201.726.125.120.620.712.410.3
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash22.265.690.4-26.56.6-32.712.5-44.6-32.3-155.4
Closing Cash Balance488.9466.2401.1310.6337.2330.1362.8350.2394.8427.6
Free Cash Flow TTM 2025202420232022202120202019201820172016
Free Cash Flow-221.0133.6-80.9-192.1-57.7-32.4-30.7-32.5-26.4-23.4-25.6
Real Free Cash Flow-246.496.7-114.2-211.9-68.0-39.3-33.1-33.3-26.5-23.4-25.6
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow19.061.982.5-29.96.1-41.32.0-47.6-33.5-141.8
Real Free Cash Flow9.652.873.2-38.9-4.7-41.32.0-47.6-39.2-147.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E24.573.1179.3
P/S7.717.8390.6
P/B13.110.8113.4
P/FCF48.2-23.6149.9
Market cap$4.2$19.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets49.1 %38.2 %0 %
Debt to Income244.2 %241.2 %0 %
Debt to Free cash flow480.5 %-75.3 %0 %
Interest expense percentage12.7 %-69.4 %11.2 %
Current ratio7.7 7.6 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE53.6 %-0.1 %0 %
ROA20.1 %-16.4 %0 %
CapEx to Revenue10.1 %16 %6 %
RaD to Revenue0 %58.1 %0 %
ROEM831,722.5 170885.8

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin60.3 %60.6 %61.9 %
Operating margin16.9 %-77.5 %17.9 %
Net margin16.2 %-87.4 %13 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding40.7 mil 27.7 mil
Employee count0.7 tis 0.3 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader